pelleas
13 Nov 2017
Re: Updated chart well blow me down; you were right. Really surprised. I really thought the sp would drive up to about 70p after the last news.
penhome
29 Oct 2017
Re: Updated chart Continuing its retrace. A break below 38 suggest a move down to 35[link] this is helpful. It's just my opinion based on what I think the chart is suggesting. This is always a balance of probabilities so my opinion can be wrong and other analysts may have differing views.
senn1965
22 Oct 2017
Re: Potential takeover target Paratek regarded as the closest peer to MTFB both have 1 antibiotic through stage 3 trials and awaiting NDA.Paratek mcap now $644mMTFB mcap now $144m (usd)[link] LSE.
senn1965
19 Oct 2017
Re: Just below. 25% There were new rules on owning 25% or more came into force this year so dipping below could be significant but who knows time will tell Senn.
pelleas
19 Oct 2017
Re: Just below. 25% Is that a thing? Can't you bid if over 25%?
senn1965
18 Oct 2017
Just below. 25% Clears the way for a bid?? With the new regs coming in this year looks like hey do not want to be above the above.
penhome
15 Oct 2017
Updated chart Almost closed the gap – bullish Friday movement and close[link]
pelleas
11 Oct 2017
Re: Potential takeover target Too early in my opinion but who knows. This unexpected pull back in the sp could encourage someone hostile!!
Tatty
06 Oct 2017
Potential takeover target With iclaprim test results looking increasingly positive, I wonder if the big pharmas are starting to sniff out an acquisition opportunity? Either way the future looks bright here.
Tatty
04 Oct 2017
Phase 3 results Impressive results without any apparent side effects. FDA approval next year would be nice. Humankind needs new antibiotics.
Ripley94
04 Oct 2017
Re: Placing successful 03/06/17Haven't the institutions done well for there ABB gift at 30p. ( nearly doubled in just four months )That's the way money is made in AIM ... up 40% today.At least my disappointment at slice not lifting a few days before has vanished lolAIM !!!
penhome
22 Sep 2017
Chart Picking up quite strongly:[link]
Tatty
16 Sep 2017
Orphan Drug Designation This is very encouraging news. For the FDA to grant this designation for live use says a lot about the potential for iclaprim. The timing is great with a number of conferences and presentations this month too.
Tatty
18 Jul 2017
RNS Consultancy So what does this person actually do? And why has the fee yo-yo'd so much? This raises more questions.
Tatty
06 Jul 2017
RNS I'm not sure what is meant by 'preventing a poster'. Is it like sticking it on a wall with blutac?MmmmAnyway I'm starting to have doubts about this, but if I read this right there will be no significant news please until October 6th?
